MESSINA, ROBERTA
 Distribuzione geografica
Continente #
EU - Europa 159
NA - Nord America 156
AS - Asia 75
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 393
Nazione #
US - Stati Uniti d'America 155
SE - Svezia 74
CN - Cina 39
IT - Italia 34
RU - Federazione Russa 31
SG - Singapore 28
IE - Irlanda 9
FI - Finlandia 5
DE - Germania 3
TR - Turchia 3
CZ - Repubblica Ceca 2
HK - Hong Kong 2
AU - Australia 1
CA - Canada 1
EU - Europa 1
FR - Francia 1
GH - Ghana 1
IN - India 1
KR - Corea 1
TW - Taiwan 1
Totale 393
Città #
Shanghai 26
Boardman 21
Singapore 21
New York 18
Ashburn 13
Lawrence 13
Princeton 13
Dublin 9
Milan 9
Rome 8
Florence 5
Helsinki 5
Moscow 5
Dallas 4
Marostica 4
Ankara 3
Seattle 3
St Petersburg 3
Camarillo 2
Hong Kong 2
Hunnebostrand 2
Prague 2
San Cipriano d'Aversa 2
Weitang 2
Beijing 1
Chelles 1
Fiesole 1
Gangseo-gu 1
Genova 1
Los Angeles 1
Munich 1
Perm 1
Pizzighettone 1
Pune 1
Santa Clara 1
Sydney 1
Xi'an 1
Totale 208
Nome #
Alterations of brain structural MRI are associated with outcome of surgical treatment in trigeminal neuralgia 31
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN) 30
Comparison of efficacy and safety of erenumab between over and under 65-year-old refractory migraine patients: a pivotal study 26
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients 23
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study 22
Assessing the role of innovative therapeutic paradigm on multiple sclerosis treatment response 19
Candesartan in migraine prevention: results from a retrospective real-world study 19
Imaging the brain and vascular reactions to headache treatments: a systematic review 18
Stress in paediatric migraine: a trigger factor? 18
Neural correlates of visuospatial processing in migraine: does the pain network help? 18
Editorial: Functional and Structural Brain Alterations in Headache: A Trait or a State? 17
Extent and characteristics of carotid plaques and brain parenchymal loss in asymptomatic patients with no indication for revascularization 16
Pathophysiological Bases of Comorbidity in Migraine 16
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 16
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study 15
DIFFERENCES IN BRAIN STRUCTURE AND FUNCTION IN PRIMARY HEADACHE DISORDERS: A MULTIMODAL MRI STUDY 15
Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience 14
Clinical correlates of hypothalamic functional changes in migraine patients 14
An update on migraine: current understanding and future directions 14
Tracking the evolution of non-headache symptoms through the migraine attack 13
Insights into migraine attacks from neuroimaging 12
Tension-type headache 12
What We Gain From Machine Learning Studies in Headache Patients 12
Editorial: Still Searching for the Origin of Migraine: From Comorbidities to Chronicization 11
Functional MRI in migraine 9
Author response: Gray matter volume modifications in migraine: A cross-sectional and longitudinal study 8
CGRP – a target for acute therapy in migraine: Clinical data 8
What imaging has revealed about migraine and chronic migraine 6
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE—The First Italian Multicenter, Prospective, Real-Life Study 1
Totale 453
Categoria #
all - tutte 5.102
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.102


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 1 0 0
2020/20219 0 0 3 0 0 4 0 0 0 0 2 0
2021/202222 0 1 1 4 0 4 5 1 1 1 2 2
2022/2023131 31 28 13 1 7 19 6 14 2 0 7 3
2023/2024221 6 10 27 17 40 25 7 32 5 5 14 33
2024/202569 54 15 0 0 0 0 0 0 0 0 0 0
Totale 453